LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
New Jersey NJ
Legislatures
2022-2023 Regular Session
Senate
Bills
S781
NJ
New Jersey Senate Bill S781
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
New Jersey 2022-2023 Regular Session
New Jersey Senate Bill S781
Introduced
1/18/22
Refer
1/18/22
Caption
Establishes requirements for State entities to enter into bulk purchasing arrangements for pharmaceutical products.
Latest NJ S781 Activity
View All Events: NJ 2022-2023 Regular Session S781
Companion Bills
No companion bills found.
Previously Filed As
NJ S1396
Establishes requirements for State entities to enter into bulk purchasing arrangements for pharmaceutical products.
NJ A4023
Establishes requirements for State entities to enter into bulk purchasing arrangements for pharmaceutical products.
NJ A1938
Establishes requirements for State to enter into contract for purchase of menstrual products.
NJ HB3613
Relating to pharmaceutical purchasing; prescribing an effective date.
NJ S749
Relative to pharmaceutical access, costs and transparency
NJ AB587
State government: pharmaceuticals: procurement: collaborative.
NJ A2318
Establishes requirements for State to enter into contract for purchase of menstrual products.
NJ S323
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
NJ S2520
Relative to pharmaceutical access, costs and transparency
NJ S2499
Relative to pharmaceutical access, costs and transparency
Similar Bills
NJ S1396
Establishes requirements for State entities to enter into bulk purchasing arrangements for pharmaceutical products.
NJ A4023
Establishes requirements for State entities to enter into bulk purchasing arrangements for pharmaceutical products.
CA AB6
Local ballot measures: statement of the measure.
CT SB01202
An Act Concerning Prescription Drug Affordability.
TX HB4990
Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.
MS SB2012
Mississippi Health Care Cost Transparency Act; enact.
CT HB06669
An Act Protecting Patients And Prohibiting Unnecessary Health Care Costs.
CT HB05384
An Act Concerning Prescription Drug Costs.